Allt inom Report

Nanexa publishes year-end report for 2022

Agreement and directed issue to Novo Nordisk, solution to patent infringement lawsuit and phase 1 study with NEX-20 started

Nanexa publishes interim report for January – September 2022

Launch of NEX-22 in type 2 diabetes and new partner projects with great potential